Editorial: Gastrointestinal cancer immunotherapy: from drug resistance mechanisms to overcoming strategies

Editorial: Gastrointestinal cancer immunotherapy: from drug resistance mechanisms to overcoming strategies

Bibliographic Details
Main Authors:	Tao Shi, Hanbing Wang, Jia Wei, Jinyan Wang, Yibo Fan, Chunlei Zheng, Xiaofang Che
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Immunology
Subjects:	gastrointestinal cancer tumor immunotherapy resistance tumor microenvironment immune checkpoint blockade
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1230591/full

Similar Items

Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives
by: Evangelos Koustas, et al.
Published: (2022-06-01)

Cancer immunotherapies: advances and bottlenecks
by: Rui Rui, et al.
Published: (2023-08-01)

Heterogeneity of the tumor immune microenvironment and its clinical relevance
by: Qingzhu Jia, et al.
Published: (2022-04-01)

Exploiting the immunomodulatory properties of chemotherapeutic drugs to improve the success of cancer immunotherapy
by: Kelly eKersten, et al.
Published: (2015-10-01)

Exosomes as smart drug delivery vehicles for cancer immunotherapy
by: Huan Zhang, et al.
Published: (2023-01-01)

Current Status and Future Perspective of Immunotherapy in Gastrointestinal Cancers
by: Zhihao Lu, et al.
Published: (2020-08-01)

Tumor microenvironment and immunotherapy of oral cancer
by: Chang Liu, et al.
Published: (2022-10-01)

Cancer Stem Cells: Devil or Savior—Looking behind the Scenes of Immunotherapy Failure
by: Lorenzo Castagnoli, et al.
Published: (2020-02-01)

Immunotherapy of targeting MDSCs in tumor microenvironment
by: Hongshu Sui, et al.
Published: (2022-09-01)

Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy
by: Cai Zhang, et al.
Published: (2020-06-01)

Targeting Natural Killer Cells for Tumor Immunotherapy
by: Cai Zhang, et al.
Published: (2020-02-01)

Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategies
by: Xianzhe Yu, et al.
Published: (2023-04-01)

Local Delivery of Immunomodulatory Antibodies for Gastrointestinal Tumors
by: Noelia Silva-Pilipich, et al.
Published: (2023-04-01)

Tumor-associated myeloid cells in cancer immunotherapy
by: Xinyu Cheng, et al.
Published: (2023-07-01)

Editorial: Tumor microenvironment, immunotherapy, and drug resistance in breast and gastrointestinal cancer
by: Xinpei Deng, et al.
Published: (2023-08-01)

Editorial: Targeting metabolism to activate T cells and enhance the efficacy of checkpoint blockade immunotherapy in solid tumors
by: Zhijia Xia, et al.
Published: (2023-07-01)

Linking Immunity with Genomics in Sarcomas: Is Genomic Complexity an Immunogenic Trigger?
by: Siddh van Oost, et al.
Published: (2021-08-01)

The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
by: Florent Petitprez, et al.
Published: (2020-05-01)

Immunotherapy Strategies for Gastrointestinal Stromal Tumor
by: Junaid Arshad, et al.
Published: (2021-07-01)

Editorial: Overcoming obstacles of cancer immunotherapy: the important role of emerging nanomedicine
by: Aimin Jiang, et al.
Published: (2024-04-01)

DNA Damage Response Evaluation Provides Novel Insights for Personalized Immunotherapy in Glioma
by: Mu Chen, et al.
Published: (2022-05-01)

CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16th Annual Meeting of the Association for Cancer Immunotherapy
by: Jan Beck, et al.
Published: (2018-12-01)

Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma
by: Zihao Yan, et al.
Published: (2021-12-01)

Immuno-Oncology: Emerging Targets and Combination Therapies
by: Henry T. Marshall, et al.
Published: (2018-08-01)

Eliciting pyroptosis to fuel cancer immunotherapy: mechanisms and strategies
by: Wuyin Wang, et al.
Published: (2022-07-01)

Tumor Microenvironment Evaluation for Gastrointestinal Cancer in the Era of Immunotherapy and Machine Learning
by: Zilan Ye, et al.
Published: (2022-05-01)

ATM Inhibition-Induced ISG15/IFI27/OASL Is Correlated with Immunotherapy Response and Inflamed Immunophenotype
by: Chi-Han Huang, et al.
Published: (2023-04-01)

CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy
by: Jan David Beck, et al.
Published: (2020-04-01)

CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy
by: Peer Andre Berger, et al.
Published: (2022-11-01)

Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion
by: Fei Li, et al.
Published: (2024-01-01)

Harnessing tumor-associated macrophages as aids for cancer immunotherapy
by: Xiaolei Li, et al.
Published: (2019-12-01)

Review to Understand the Crosstalk between Immunotherapy and Tumor Metabolism
by: Pratibha Pandey, et al.
Published: (2023-01-01)

Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma
by: Ye Xiong, et al.
Published: (2022-09-01)

PD-1/PD-L blockade in gastrointestinal cancers: lessons learned and the road toward precision immunotherapy
by: Junyu Long, et al.
Published: (2017-08-01)

Engineering ROS‐Responsive Bioscaffolds for Disrupting Myeloid Cell‐Driven Immunosuppressive Niche to Enhance PD‐L1 Blockade‐Based Postablative Immunotherapy
by: Shaoyue Li, et al.
Published: (2022-04-01)

The Current Landscape of Immune Checkpoint Blockade in Metastatic Lung Squamous Cell Carcinoma
by: Hong Yuan, et al.
Published: (2021-03-01)

Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment
by: Ruiwen Ruan, et al.
Published: (2023-03-01)

Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?
by: Clara Martori, et al.
Published: (2022-01-01)

Advances of Tumorigenesis, Diagnosis at Early Stage, and Cellular Immunotherapy in Gastrointestinal Malignancies
by: Haipeng Zhu, et al.
Published: (2021-08-01)

The next wave of cellular immunotherapies in pancreatic cancer
by: Dannel Yeo, et al.
Published: (2022-03-01)